Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments (2016 - 2026)

Amphastar Pharmaceuticals' Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $15.5 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 45.2% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $77.5 million (down 27.44% YoY), while the FY2025 annual figure was $90.3 million, down 28.35% from the prior year.
• Change in Acquisitions & Divestments was $15.5 million for Q1 2026 at Amphastar Pharmaceuticals, down from $16.4 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $65.8 million in Q2 2024 to a low of -$179000.0 in Q4 2023.
• Historically, Change in Acquisitions & Divestments has averaged $17.6 million across 5 years, with a median of $13.6 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments sank 101.43% in 2023, then jumped 4281.01% in 2024.
• A 5-year view of Change in Acquisitions & Divestments shows it stood at $12.5 million in 2022, then sank by 101.43% to -$179000.0 in 2023, then surged by 4281.01% to $7.5 million in 2024, then jumped by 119.7% to $16.4 million in 2025, then retreated by 5.72% to $15.5 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $15.5 million (Q1 2026), $16.4 million (Q4 2025), and $22.5 million (Q3 2025), per Business Quant data.